Europe requires new antibiotics, but big pharma refuses to supply them
Companies are no longer investing in these medications and are requesting a “premium” from the EU to reverse the trend. In the background, antimicrobial resistance […]
Companies are no longer investing in these medications and are requesting a “premium” from the EU to reverse the trend. In the background, antimicrobial resistance […]
